NCT01736657

Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients

Evaluation of the Spectra Optia Apheresis Red Blood Cell Exchange Protocol in Patients With Sickle Cell Disease.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 73 (actual)
• Sponsor: Terumo BCT · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the performance of the Spectra Optia system red blood cell exchange (RBCx) protocols (exchange and depletion/exchange) in study participants with sickle cell disease.

Detailed description

Evaluate the performance of the Spectra Optia system red blood cell exchange (RBCx) protocols (exchange and depletion/exchange) in study participants with sickle cell disease. Open label design.

Conditions

• Sickle Cell Disease

Interventions

Type	Name	Description
DEVICE	Red blood cell exchange in sickle cell	One Red Blood Cell Exchange using Spectra Optia Apheresis System per enrolled patient

Timeline

• Start date: 2012-11-01
• Primary completion: 2013-06-01
• Completion: 2013-06-01
• First posted: 2012-11-29
• Last updated: 2014-07-14
• Results posted: 2014-07-14

Locations

5 sites across 1 country: United States